Real-world study of the efficacy and safety of bevacizumab for first-line and post-first-line treatment of advanced RAS mutated colorectal cancer
收藏NIAID Data Ecosystem2026-03-12 收录
官方服务：
资源简介：
Interventions: experimental group:chemotherapy combined with bevacizumab Primary outcome(s): Progression-Free Survival;Overall Survival Study Design: Sequential
创建时间：
2021-02-15
